# An Open-Label Study to Evaluate the Safety and Efficacy of PRX-08066 in Patients With Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease

> **NCT00677872** · PHASE2 · TERMINATED · sponsor: **Epix Pharmaceuticals, Inc.** · enrollment: 40 (estimated)

## Conditions studied

- COPD
- Pulmonary Hypertension

## Interventions

- **DRUG:** PRX-08066

## Key facts

- **NCT ID:** NCT00677872
- **Lead sponsor:** Epix Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-05
- **Primary completion:** 2008-12
- **Final completion:** —
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2009-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00677872

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00677872, "An Open-Label Study to Evaluate the Safety and Efficacy of PRX-08066 in Patients With Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00677872. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*